Both semaglutide (the active ingredient in Wegovy) and tirzepatide (the active ingredient in Mounjaro) effectively cause the body to produce more glucagon-like peptide 1 (GLP-1), which then causes your body to create more insulin
No statements about human bone health can be derived from it
By Brianna Manginelli, MS, CNS LDN, DSS Fusion Functional Nutritionist As we struggle to overcome the obesity epidemic in the US, the new FDA-approved weight loss medications are unquestionably front of mind
A weight loss rate of approximately 1 to 2 pounds per week is generally considered safe and sustainable
Dunger, who planned and supervised this study, died on 20 July 2021 before publication of this work
While causation was not established, melanocyte stimulation warrants ongoing vigilance